Thromboprophylaxis for atrial fibrillation

Lancet. 1999 May 8;353(9164):1620-1. doi: 10.1016/S0140-6736(05)75742-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects*
  • Atrial Fibrillation / prevention & control*
  • Hemorrhage / chemically induced*
  • Humans
  • Randomized Controlled Trials as Topic
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Warfarin